Open AccessChemotherapy-Induced Amenorrhea in Patients With Breast Cancer With a BRCA1 or BRCA2 Mutation
Author(s) -
Adriana Valentini,
Amy Finch,
Jan Lubiński,
Tomasz Byrski,
Parviz Ghadirian,
Charmaine KimSing,
Henry T. Lynch,
Peter Ainsworth,
Susan L. Neuhausen,
Ellen Greenblatt,
Christian Singer,
Ping Sun,
Steven A. Narod
Publication year - 2013
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2012.47.7893
Subject(s) - medicine , chemotherapy , breast cancer , oncology , mutation , amenorrhea , cancer , gynecology , genetics , pregnancy , gene , biology
To determine the likelihood of long-term amenorrhea after treatment with chemotherapy in women with breast cancer who carry a BRCA1 or BRCA2 mutation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom